Error: Could not add to watchlist. X

Optimer Pharmaceuticals Inc

+ Watchlist
XYH:GR
Stuttgart
Price not available for XYH:GR
EUR
Volume
0
Previous Close
9.19
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-
Market Cap (EUR)
-
Shares Outstanding
-
Price/Sales (TTM)
-
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Specialty Pharma

Related Videos

There are currently no related videos for this ticker. Please check back later.
There are currently no news stories for this ticker. Please check back later.
There are currently no press releases for this ticker. Please check back later.
Profile
Optimer Pharmaceuticals, Inc. discovers, develops, and commercializes anti infective products. Optimer's initial development efforts address products that treat gastrointestinal infections (GI), and related diseases, including diminished efficacy, serious adverse side effects, drug-to-drug interactions, difficult patient compliance, and bacterial resistance.
ADDRESS
101 Hudson Street
Suite 3501
Jersey City, NJ 07302
United States
PHONE
1-201-333-8819
WEBSITE
-
  • Eric Sirota
    Chief Operating Officer
  • Meredith Schaum
    Chief Compliance Ofcr/Gen Cnsl
  • Sherwood L Gorbach
    Senior VP/Chief Scientific Ofcr
  • Linda E Amper
    Senior VP:Human Resources
  • David A Walsey
    VP:Investor Relations
Show More